80 What is Autism?
48 Chaste P, Klei L, Sanders SJ, et al. (2015). A genome‐wide association study of
autism using the Simons Simplex Collection: Does reducing phenotypic
heterogeneity in autism increase genetic homogeneity? Biol. Psychiatry,
77 (9):775–84.
49 Chaste P, Roeder K, Devlin B (2017). The yin and yang of autism genetics:
How rare de novo and common variations affect liability. Annu. Rev. Genomics
Hum. Genet. DOI: 10.1146/annurev‐genom‐083115‐022647.
50 Chaste P, Leboyer M (2012). Autism risk factors: genes, environment, and
gene‐environment interactions. Dialogues Clin. Neurosci., 14 (3):281–92.
51 Gaugler T, Klei L, Sanders SJ, et al. (2014). Most genetic risk for autism resides
with common variation. Nat. Genet., 46 (8):881–5.
52 Sanders SJ, Murtha MT, Gupta AR, et al. (2012). De novo mutations revealed
by whole‐exome sequencing are strongly associated with autism. Nature,
485 :237–41.
53 Sebat J, Lakshmi B, Malhotra D, Troge J (2007). Strong association of de novo
copy number mutations with autism. Science, 316 :445–9.
54 Sanders SJ, Ercan‐Sencicek AG, Hus V, et al. (2011). Multiple recurrent de
novo CNVs, including duplications of the 7q11.23 Williams syndrome region,
are strongly associated with autism. Neuron, 70 :863–85.
55 Pinto D, Delaby E, Merico D, et al. (2014). Convergence of genes and cellular
pathways dysregulated in autism spectrum disorders. Am. J. Hum. Genet.,
94 :677–94.
56 Klei L, Sanders SJ, Murtha MT, et al. (2012). Common genetic variants, acting
additively, are a major source of risk for autism. Mol. Autism, 3 :9.
57 Vergés L, Molina O, Geán E, et al. (2014). Deletions and duplications of the
22q11.2 region in spermatozoa from DiGeorge/velocardiofacial fathers. Mol.
Cytogenet., 7 : 86.
58 Kong HE, Zhao J, Xu S, et al. (2017). Fragile X‐associated tremor/ataxia
syndrome: From molecular pathogenesis to development of therapeutics.
Front Cell Neurosci., 11 :128.
59 Caban C, Khan N, Hasbani DM, Crino PB (2016). Genetics of tuberous
sclerosis complex: implications for clinical practice. Appl. Clin. Genet., 10:1–8.
60 Krueger DA, Northrup H; International Tuberous Sclerosis Complex
Consensus Group (2013). Tuberous sclerosis surveillance and management:
recommendations of the 2012 International Tuberous Sclerosis Comples
Consensus Conference. Pediatr. Neurol., 49 (4):255–65.
61 Gipson TT, Poretti A (2017). Implementing a multidisciplinary approach to
treating tuberous sclerosis complex: A case report. Child Neurol. Open,
4 :2329048X17725609.
62 Müller RA, Amaral DG (2017). Editorial: Time to give up on autism spectrum
disorder? Autism Res., 10 :10–14.
63 Waterhouse L, London E, Gillberg C (2016).ASD validity. Rev. J. Autism Dev.
Disord., 3 :302–29.